Centre for Health Research and Development, Society for Applied Studies, 45 Kalu Sarai, New Delhi 110016, India.
BMJ. 2012 Mar 21;344:e1634. doi: 10.1136/bmj.e1634.
To evaluate the Indian Integrated Management of Neonatal and Childhood Illness (IMNCI) programme, which integrates improved treatment of illness for children with home visits for newborn care, to inform its scale-up.
Cluster randomised trial.
18 clusters (population 1.1 million) in Haryana, India.
29,667 births in intervention clusters and 30,813 in control clusters.
Community health workers were trained to conduct postnatal home visits and women's group meetings; physicians, nurses, and community health workers were trained to treat or refer sick newborns and children; supply of drugs and supervision were strengthened.
Neonatal and infant mortality; newborn care practices.
The infant mortality rate (adjusted hazard ratio 0.85, 95% confidence interval 0.77 to 0.94) and the neonatal mortality rate beyond the first 24 hours (adjusted hazard ratio 0.86, 0.79 to 0.95) were significantly lower in the intervention clusters than in control clusters. The adjusted hazard ratio for neonatal mortality rate was 0.91 (0.80 to 1.03). A significant interaction was found between the place of birth and the effect of the intervention for all mortality outcomes except post-neonatal mortality rate. The neonatal mortality rate was significantly lower in the intervention clusters in the subgroup born at home (adjusted hazard ratio 0.80, 0.68 to 0.93) but not in the subgroup born in a health facility (1.06, 0.91 to 1.23) (P value for interaction = 0.001). Optimal newborn care practices were significantly more common in the intervention clusters.
Implementation of the IMNCI resulted in substantial improvement in infant survival and in neonatal survival in those born at home. The IMNCI should be a part of India's strategy to achieve the millennium development goal on child survival.
Clinical trials NCT00474981; ICMR Clinical Trial Registry CTRI/2009/091/000715.
评估印度综合新生儿和儿童疾病管理(IMNCI)方案,该方案将改善儿童疾病治疗与新生儿家庭访视相结合,为其推广提供信息。
整群随机试验。
印度哈里亚纳邦的 18 个集群(人口 110 万)。
干预组 29667 例分娩,对照组 30813 例分娩。
培训社区卫生工作者进行产后家访和妇女小组会议;培训医生、护士和社区卫生工作者治疗或转诊患病新生儿和儿童;加强药品供应和监督。
新生儿和婴儿死亡率;新生儿护理实践。
干预组婴儿死亡率(校正危害比 0.85,95%置信区间 0.77 至 0.94)和 24 小时后新生儿死亡率(校正危害比 0.86,0.79 至 0.95)显著低于对照组。新生儿死亡率的校正危害比为 0.91(0.80 至 1.03)。除新生儿后期死亡率外,所有死亡率结局的出生地点与干预效果之间存在显著交互作用。在家中出生的亚组中,新生儿死亡率显著降低(校正危害比 0.80,0.68 至 0.93),而在医疗机构出生的亚组中则无显著降低(1.06,0.91 至 1.23)(交互作用 P 值=0.001)。在干预组中,优化的新生儿护理实践更为常见。
实施 IMNCI 可显著提高婴儿存活率和在家中出生的新生儿存活率。IMNCI 应成为印度实现儿童生存千年发展目标战略的一部分。
临床试验 NCT00474981;ICMR 临床试验注册 CTRI/2009/091/000715。